Fresenius Medical Care (NYSE: FMS) reported Q2 EPS of EUR0.81, EUR0.19 better than the analyst estimate of EUR0.62. Revenue for the quarter came in at EUR4.86 billion versus the consensus estimate of EUR5.55 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.